chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a patient (age and gender not reported) who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). Subsequently the patient experienced an injection site reaction. The patient sought unspecified medical attention. The patient's status was reported as "improved after a couple of days". There was no product quality complaint involved. Attempts are being made to obtain additional identifying information to distinguish the individual patient mentioned in this report. Additional information will be provided if available. This is on of several reports received from the same source. Additional information has been requested.
Symptoms are malaise / fatigue , low grade fever( 99F) , ears  feel warm, mild stomach upset with low appetite.
24 hours after vaccination, flu-type symptoms that lasted 36 hours. 1 week later, increased GI pain that brought us to the ER then to a GI specialist.
-fever for 1-2 days -chills the night of the injection, for only 1 night -soreness at site of injection and most of lower shoulder area, for about a week -fatigue, severe for at least 2 days -headache, for about 3 days -muscle pain, for about a week -swollen lymph node in right armpit, showed up 2 days after injection, lasted about 3 days
soreness at injection site; Shivering; Fever; arm soreness; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 30th January 2022, the patient received the 2nd dose of Shingrix. On 30th January 2022, less than a day after receiving Shingrix, the patient experienced injection site pain, shivering, fever and pain in arm. On an unknown date, the outcome of the injection site pain, fever and pain in arm were not recovered/not resolved and the outcome of the shivering was recovered/resolved.   It was unknown if the reporter considered the injection site pain, shivering, fever and pain in arm to be related to Shingrix.  Additional details were reported as follows: The patient received second dose of Shingrix and same night 6 to 8 hours later experienced shivering, injection site pain, fever and pain in arm.  Shivering was recovered but other events were not recovered at the time of reporting. The patient's body temperature at the time of reporting was 99.1 F. Consent to follow up was granted.
Skipped periods and experienced hot flashes four months following my first dose. Period resumed August, 2021.
Feeling dizziness with intermittent numbness of lips after receiving immunizations. No syncope. Vitals normal. Pt. alert and oriented.
Morning after vaccines, temp 102.3 degrees, severe headache, stiff and painful neck, nausea and vomiting and dizziness/weakness with CSF C/W viral meningitis.
After vaccine administered pt became diaphoretic and pale. C/o vertigo. Pulse and B/P dropped. B/P 88/56 (R) sitting. 50mg diphenhydramine given po. Pulse at 55 bpm. Pt stated that she gets worked up for medical procedures, denies any meds or diagnoses. Pt given Coke to drink, equip removed from room. In 30 min B/P increased 104/74 and pulse 70. States she is ok. No hives or respiratory c/o's.
Patient states woke up Sunday morning and his hand was numb. He was fine before then. The numbness has been improving but currently 4 days out he still has some hand weakness/numbness.
24 hours after receiving vaccine she developed fatigue, headache, chills, myalgias, diarrhea, possibly rash (but has psoriasis)
9/25/2020 6:57pm patient got immunization patient got up about 5 minutes later started to looked pale and weak, sat back down and had a fainting spell, breathing was slow and patient was clammy for about 5 minutes. patient was then lowered onto his back with legs in the air and started to become normal in color again. EMS was called and evaluated the patient he then walked out on his own with his mother
Patient is a 57 y.o. woman with PMH significant for paroxysmal AFib on Xarelto, sick sinus syndrome, diastolic congestive heart failure, history of CVA with residual left-sided weakness obstructive sleep apnea on CPAP and seizure disorder presented to emergency department for right-sided weakness, tingling numbness and slow speech.   According to patient she started having symptoms yesterday evening.  Also she was having cough with expectoration and shortness of breath, sore throat, headache, loss of sensation of taste and smell and fever on Monday.  Given the symptoms she presented to emergency department for further evaluation.   In emergency department she were tested positive for COVID-19.  CT imaging of head, angiogram of head and neck showed chronic findings.  Neurology evaluated patient and recommended to rule out acute stroke.   At the time of interview patient is complaining of right-sided weakness, slowing of speech, shortness of breath, cough, on and off fever, loss of sensation of taste and smell, soreness in throat and headache.  Patient seen evaluated.  Presents for today(11-9-21) for evaluation of stroke-like symptoms.  Took upon presentation to the bedside code stroke was activated.  Patient is still having some symptoms however symptoms are not quite focal.  As last well known is 1800 yesterday and is well as her being on anticoagulation she is not a candidate for tPA.  CT head shows no acute CVA.  There are multiple focal sites of chronic infarction.  CT perfusion reveals no evidence of infarct core critical hypoperfusion.  CT angiogram head neck shows no new intracranial large vessel occlusion.  There is severe chronic stenosis of the left middle cerebral artery proximal M1 segment and moderate stenosis of the distal right middle cerebral artery.  Complete blood count reveals normal white count.  Hemoglobin mildly anemic 11.8.  Platelet count 134. COVID screen is positive.  Patient was hypoxic initially 87% upon my arrival to the room when she 1st presented.  She did require 2 L supplemental oxygen.  She was started on Decadron 6 mg. Chest x-ray did show possible of point vascular congestion versus early infection.  BNP only 799. She remained stable condition saturating well on 2 L at this time no acute respiratory distress.  She will be admitted to the hospitalist for stroke workup along with further treatment of her COVID-19.
Blood clot; Random bruise on knuckle; Joint pain; Rash; This is a spontaneous report received from a contactable consumer (patient). A 57-year-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, LOT/Batch number and expiration date unknown) via an unspecified route of administration on 14Apr2021 at 04:00 PM at age of 57-year-old at single dose, unknown dose number for COVID-19 immunization. Patient was not pregnant at time of vaccination and at time of events onset. Medical history included known allergies (unspecified). Compound heft (pending clarification) was reported as other medical history. Prior to vaccination, it was unknown if patient was diagnosed with COVID-19. Since the vaccination, the patient wasn't tested for COVID-19. Concomitant medications included supplements in two weeks. Patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient had rash on day 10 on 24Apr2021 at 03:00 PM, joint pain on day 11 (25Apr2021), day 12 (26Apr2021), day 13 (27Apr2021) and a blood clot and random bruise on knuckle on day 14 (28Apr2021). Events didn't result in emergency room visit or physician office visit. No treatment received for the events. Outcome of events was recovering.  Information about Lot/Batch number has been requested.
This spontaneous report as received from a certified medical assistant refers to a patient of unknown demographics. On an unknown date, the patient was vaccinated with a dose of improperly stored GARDASIL (Lot number, expiry date, route and dose were not reported). The certified medical assistant reported that the vaccine was exposed to temperature of 26 F (Fahrenheit) for a total of 135 hours. No adverse effects reported. Follow-up received. Certified medical assistant stated that other 104 children received GARDASIL. Follow up information has been received from the certified medical assistant regarding a 9 years old, male patient with no pertinent medical history reported. On 21-DEC-2012 the patient was vaccinated with the first dose of GARDASIL (lot number and expiration date not reported) (intramuscular on the left arm, dose not reported). It was reported that the patient did not seek medical attention. This is one of several reports from the same source. Additional information is not expected.
My symptoms began the morning after I woke up from having the flu shot the previous afternoon with a finger that I could not move and breathing difficulty. This progressed over the following months to incredible pain and immobility in all of the joints and muscles throughout my entire body along with incredible fatigue, muscle spasms and twitches and a host of other symptoms affecting every organ, muscle, joint and nervous system. Almost two years after the flu shot, I am still dealing with the muscle/joint pain in my entire neck and back.  It took 9 doctors and 8 months for someone to figure out what the flu shot had done to me which was an inflammatory response of the peripheral nervous system which impacted the facia throughout my body. Previous to the diagnosis I had seen rheumatologists, neurologists and other doctors to try and figure out how to rid my body of this terrible pain and the impact that it was having on my life. I had symptoms similar to Lyme disease, MS etc but I did not have a disease, I had a reaction. I was repeatedly tested for these. I have spent almost every single week since that flu shot going to a doctors appointment, chiropractic appointments and physical massage therapy appointments to relieve the constant pain, stiffness and soreness in my muscles. This has taken not only my time but a great deal of out of pocket money spent on trying to get better from this. Thousands of dollars have been spent through insurance and personal funds to improve the damage that the flu shot has caused. It has been an absolutely terrible experience to be a perfectly healthy person one day and to have this much daily pain the two years since then. I would like for someone from VAERS to contact me to discuss my case. I will be able to provide all medical information, records and expenses as a result of this experience.
The day after getting my second dose I had extreme body pain from head to toe. My glands under my arms and in my groin area swelled up, I had a severe headache in the front and back of head my facial sinus area was in pain, It hurt to breathe, complete body weakness and fatigue , I had chills at first with a low grade fever 100.03  then I broke in to a sweat many hours later. I spent a good 30 plus hours being bed ridden with intense pain. These symptoms lasted for aproximatly 36 hours total.
Heart palpitations and light-headedness. Bad EKG  Diagnosed as electrical problem at right ventricle.
I got extreme red rash over most of my body. Started with arm pits,  back, groin and abdominal areas. The rash eventually covered entire body including portions of my face. The rash consisted of bright red blotches and much tendency to itch.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concurrent conditions, medical history, or concomitant medications. On or about 23-APR-2013, a pharmacist at a pharmacy administered ZOSTAVAX to the patient to obtain permanent prevention and protection against shingles and zoster-related injuries/conditions (dose, route, and lot # not provided). On or about 03-JAN-2017, the patient was treated by a physician's assistant at a family medicine office for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with ZOSTAVAX, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of ZOSTAVAX, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was not recovered. Causality assessment was related. Additional information has been requested.
Homeless patient did not have paper card. Was given Moderna vaccine on 5/13/21. Pt received 2-dose series for Pfizer on (3/2/21 and 3/23/21)  No side effects noted after dose 1 Moderna.
Information has been received from the authors in a literature article, concerning a 17 year old female patient. The patient's concurrent conditions, medical history, allergies, and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with the first dose of GARDASIL as prevention of human papilloma virus (HPV) infection (strength, dosage schedule, route, anatomical location, lot number and expiration date were not reported). On an unknown date, two weeks after the vaccine was administered, the patient presented with blurry vision in the right eye, diagnosed with right optic neuritis. On an unknown date, the patient was hospitalized. Then, on an unknown date, a magnetic resonance imaging (MRI) of the brain showed right frontal enhancing lesion. The patient was discharged from the hospital on an unknown date. One week after discharge, she experienced intermittent numbness and weakness in her lower extremities, and blurry vision in the right eye. Repeat MRI of the brain showed new left parieto-occipital enhancing lesion; it was reported that the patient experienced multiple sclerosis (MS). On unknown dates, a cerebrospinal fluid (CSF) showed presence of oligoclonal bands, magnetic resonance imaging (MRI) of the brain showed presence of white matter lesions with periventricular and corpus collosal involvement, and the rest of the work-up was unremarkable including neuromyelitis optica (NMO) antibody. The patient was treated with intravenous (IV) steroids for relapses, and started on disease modifying therapy with interferon beta-1a for relapsing remitting MS after second event. She did not receive further doses GARDASIL. The patient was followed for two years. The authors indicated that this case and the others that had been previously reported, suggested a temporal association between HPV vaccination and onset of MS. Although live, attenuated vaccines had generally not recommended in MS patients, quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL) is an inactivated and recombinant vaccine, and does not contain any viral DNA. Whether the vaccine increases the risk of the initial demyelinating event in an already predisposed population or triggers the onset of MS, by way of an immune response, remains to be studied. Upon internal review, the multiple sclerosis was considered medically significant event. This is one of two cases from the same literature article (MARRS# 1804USA008385). Sender's Comments: US-009507513-1804USA008385:
2 days after receiving vaccine patient had noticed a red rash slightly larger than the size of a quarter. Day 3, the rash is still present but minimal swelling. Patient can feel a lump still.
It was 7/8 days after, I woke up very weak walking to the bathroom and tried to lift my arm and legs, My balance has been an issue so I have to be careful because I cannot stand on my own feet and my grasp I keep dropping it and I cannot maintain my grasp. It doesn't sound much but brushing my teeth in the morning I cry because I can't even do that on my own. I feel so weak and I sometime need both of my hands to get the Toothpaste and I can't use my a glass because everything I drop and it breaks so Now I have to use paper or plastic, I did not use a cane or walker, I can't no longer walk my dog because I will drop the the leash and I can't no longer drive because I can't maintain the grasp on the wheel and I couldn't maintain at all.  I'm afraid of doing anything on my own. After almost 23 days I gradually recovered.
patient was accidentally given a dose of Infanrix instead of Boostrix; Inappropriate age at vaccine administration; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 33-year-old female patient who received DTPa (Infanrix) (batch number 7KM94, expiry date 10-JUN-2023) for prophylaxis.   On 06-APR-2023, the patient received Infanrix. On 06-APR-2023, an unknown time after receiving Infanrix, the patient experienced wrong vaccine administered (Verbatim: patient was accidentally given a dose of Infanrix instead of Boostrix) and inappropriate age at vaccine administration (Verbatim: Inappropriate age at vaccine administration). The outcome of the wrong vaccine administered and inappropriate age at vaccine administration were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 11-MAY-2023 A nurse called to report that a patient was accidentally given a dose of Infanrix instead of Boostrix. The reporter requested to know how to proceed with the vaccinations. They were unsure of previous vaccines given or current vaccination status.  Vaccine, patient and vaccination information was provided. The Vaccine Administration Facility is the same as Primary Reporter. The reporter consented to follow up. The reporter reported that a 33 year old patient was given Infanrix instead of Boostrix, which led to wrong vaccine administered and inappropriate age at vaccine administration.
shingles; Information has been received from a lawyer, regarding a case in litigation, and refers to a patient (pt) of unknown age and gender. No information about the pt's medical history, concurrent conditions and concomitant medications was provided. On an unknown date in 2015, the pt was inoculated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, anatomical location, lot # and expiration date were not provided) as prescribed and/or administered by a pharmacist at a pharmacy for the long-term prevention of shingles and/or zoster-related conditions. On an unknown date, subsequent to inoculation with zoster vaccine live (ZOSTAVAX), the pt was treated by a healthcare provider for shingles. As a direct and proximate result of the pt's use of zoster vaccine live (ZOSTAVAX), the pt had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future. The outcome of the event was considered to be not recovered. The reporter considered the event of shingles to be related to zoster vaccine live (ZOSTAVAX).
Heartburn; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 09Apr2021 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included allergies to penicillin and sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 10Apr2021, the patient experienced heartburn. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the event which included treatment with unspecified antacid and omeprazole (MANUFACTURER UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event heartburn was resolved on an unspecified date in 2021. The patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the right arm on 30Apr2021 (at the age of 36-years-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are possible. No further information is expected.
Fever dose 2-fever reported, called off work today  Narrative: dose 2-fever reported, called off work today
fatigue, chills, body aches, shortness of breath, tachycardia, nausea, headache
This spontaneous report as received from a medical assistant refers to multiple patients of unknown age and gender. The patients' concurrent conditions, medical history and concomitant medications were not reported. On unknown dates, the patients were vaccinated with improperly stored ZOSTAVAX, lot # M038864, expiry date 20-DEC-2017 (dose, route and site of administration were not reported) for prophylaxis. No adverse effects reported. Administered vaccines experience temperature excursion of 1.9 degrees Celsius for 6 weeks and 5 days. There were no previous temperature excursion. Data logger was not involved. Additional information has been requested.
Client reports she developed metallic taste and sense of smell 4 days post vaccination.  Client reports these symptoms lasted 5 months and still has metallic taste when she drinks soda.  Client denies any other symptoms.  Client did not  follow up with primary care provider, did not seek treatment.
Thursday morning the day after receiving the 4th booster vaccine I woke up and could not speak properly; I was mumbling words. My family thought I was having a stroke and called 911. The ambulance came and rushed me to the hospital. At the hospital my blood pressure was elevated in the 190's and I was having a headache. My speech was normal again. The next day, my speech was bad again and I was agitated. They did an MRI of my brain and did not find evidence of stroke or TIA. They told me I had suffered a seizure related to hypertension and possibly Posterior reversible encephalopathy syndrome (PRES). I was discharged after 4 nights, 5 days in the hospital.
Post vax, the pt became lightheaded and faint. Ammonia inhalant given along with ice packs.
Loss of Sensation down neck across chest and shoulder. Saw Internist and Neuroligst.  Took steroids and getting MRI.
Sleeps 18-20 hours a day, sharp pains in eyes, muscles hurt, brain fog, period issues and 2 strains of Lyme disease. Trying to treat Lyme but had many test and has Chronic Fatigue Syndrome.
Patient was not scheduled for his appointment at this site. Unfortunately, he was told he could receive his booster shot today. screener failed to verify if patient was on the system. vaccinator EMT delivered vaccine without verifying information. Incident was reported to Staff. incident will be reported to VAERS and an incident report will be generated he received his first dose on 03/28/2021 at a different facility. He was scheduled at that same facility for his booster shot on 4/28/21.
Patient came to me c/o rash on L side chest and neck thinking it may have been from injection 2 days prior. Denied SOB or CP. Pt stated onset was the day of injection.